Yttrium-Doped Iron Oxide Nanoparticles for Magnetic Hyperthermia Applications

Magnetic nanoparticles of Fe3O4 doped by different amounts of Y3+ (0, 0.1, 1, and 10%) ions were designed to obtain maximum heating efficiency in magnetic hyperthermia for cancer treatment. Single-phase formation was evident by X-ray diffraction measurements. An improved magnetization value was obta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of physical chemistry. C 2020-03, Vol.124 (12), p.6871-6883
Hauptverfasser: Kowalik, Przemyslaw, Mikulski, Jakub, Borodziuk, Anna, Duda, Magdalena, Kamińska, Izabela, Zajdel, Karolina, Rybusinski, Jaroslaw, Szczytko, Jacek, Wojciechowski, Tomasz, Sobczak, Kamil, Minikayev, Roman, Kulpa-Greszta, Magdalena, Pazik, Robert, Grzaczkowska, Paulina, Fronc, Krzysztof, Lapinski, Mariusz, Frontczak-Baniewicz, Małgorzata, Sikora, Bozena
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Magnetic nanoparticles of Fe3O4 doped by different amounts of Y3+ (0, 0.1, 1, and 10%) ions were designed to obtain maximum heating efficiency in magnetic hyperthermia for cancer treatment. Single-phase formation was evident by X-ray diffraction measurements. An improved magnetization value was obtained for the Fe3O4 sample with 1% Y3+ doping. The specific absorption rate (SAR) and intrinsic loss of power (ILP) values for prepared colloids were obtained in water. The best results were estimated for Fe3O4 with 0.1% Y3+ ions (SAR = 194 W/g and ILP = 1.85 nHm2/kg for a magnetic field of 16 kA/m with the frequency of 413 kHz). The excellent biocompatibility with low cell cytotoxicity of Fe3O4:Y nanoparticles was observed. Immediately after magnetic hyperthermia treatment with Fe3O4:0.1%Y, a decrease in 4T1 cells’ viability was observed (77% for 35 μg/mL and 68% for 100 μg/mL). These results suggest that nanoparticles of Fe3O4 doped by Y3+ ions are suitable for biomedical applications, especially for hyperthermia treatment.
ISSN:1932-7447
1932-7455
DOI:10.1021/acs.jpcc.9b11043